Knockdown of FOXD1 decreased the viability and colony formation of PC-3 and 22Rv1 cells, while overexpression of FOXD1 exhibited opposite effects, implying that FOXD1 might be a tumor-promoter in prostate cancer cells. This evidence concerns the gene FOXD1 and prostate carcinoma.